Managing Dyslipidemia in Type 2 Diabetes

Adam J. Nelson, Simon K. Rochelau, Stephen J. Nicholls

Research output: Contribution to journalReview articlepeer-review

17 Citations (Scopus)


Cardiovascular disease is the most frequent cause of morbidity and mortality among individuals with diabetes and although there has been significant reduction in excess risk, these individuals remain at least twice as likely to sustain atherosclerotic events. Aggressive management of traditional factors, such as dyslipidemia, remains the cornerstone of risk mitigation. Diabetes and its associated insulin resistance generate qualitative and quantitative changes in lipid profile, which complicate effective treatment. This review summaries the background to diabetic dyslipidemia and provides a précis of the available management options.

Original languageEnglish
Pages (from-to)153-173
Number of pages21
JournalEndocrinology and Metabolism Clinics of North America
Issue number1
Publication statusPublished or Issued - Mar 2018


  • Diabetes
  • Dyslipidemia
  • LDL
  • Statin
  • Triglycerides

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this